Janux Therapeutics JANX Q2 2025 earnings
Reported August 7, 2025 · Before market open
Revenue-
EPS-$0.55Miss by $0.07
EPS estimate-$0.48
Next report
Aug 6, 2026 (In 1 week)Revenue estimate$19.1M
EPS estimate-$0.26
Financials
Q2 2025Valuation & ratios
Versus estimates
Ask the moment Janux Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Janux Therapeutics report Q2 2025 earnings?
- Janux Therapeutics (JANX) reported Q2 2025 earnings on August 7, 2025 before market open.
- What were Janux Therapeutics's Q2 2025 revenue and EPS?
- Janux Therapeutics reported revenue of - and eps of $-0.55 for Q2 2025.
- Did Janux Therapeutics beat estimates in Q2 2025?
- EPS missed the consensus estimate of $-0.48 by $0.07.
- How did Janux Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 100.0% from $8.9M a year earlier and eps declined 400.0% from $-0.11.
- Where can I find Janux Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-105069) directly on SEC EDGAR. The filing index links above go to sec.gov.